Researchers track cancer response to standard drugs in HIV patients
NCT ID NCT06480773
Summary
This study observes how HIV-related Kaposi Sarcoma, a type of cancer, responds to standard chemotherapy treatments given in Malawi and South Africa. It follows 127 adult patients already receiving standard care to understand why outcomes vary and identify markers that could predict who benefits most from treatment. The goal is to gather knowledge that could help doctors personalize future treatment plans.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stellenbosch University and Tygerberg Hospital
Cape Town, Stellenbosch, 8000, South Africa
-
UNC Project, Kamuzu Central Hospital
Lilongwe, Malawi
Conditions
Explore the condition pages connected to this study.